Receptor activity and turnover of dopamine and noradrenaline after neuroleptics - PubMed (original) (raw)
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
N E Andén et al. Eur J Pharmacol. 1970.
No abstract available
Similar articles
- Mode of action of L-DOPA on central noradrenaline mechanisms.
Andén NE, Engel J, Rubenson A. Andén NE, et al. Naunyn Schmiedebergs Arch Pharmacol. 1972;273(1):1-10. doi: 10.1007/BF00508076. Naunyn Schmiedebergs Arch Pharmacol. 1972. PMID: 4260802 No abstract available. - [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
Degkwitz R. Degkwitz R. Med Klin. 1969 Aug 15;64(33):1451-6. Med Klin. 1969. PMID: 4896563 Review. German. No abstract available. - The neuroleptics. 6. Clinical and experimental electroencephalography.
Borenstein P, Dongier M, Fink M, Florio V, Itil TM, Longo VG, Mellerio F, Naquet R, Pampiglione G, Titeca J, Verdeaux G. Borenstein P, et al. Mod Probl Pharmacopsychiatry. 1970;5:109-25. Mod Probl Pharmacopsychiatry. 1970. PMID: 5005609 No abstract available. - [The antipsychotic action of neuroleptics and basal ganglia function].
Arushanian EB. Arushanian EB. Farmakol Toksikol. 1973 Jul-Aug;26(4):481-9. Farmakol Toksikol. 1973. PMID: 4151298 Review. Russian. No abstract available. - [Neuroleptics--phenothiazine and butyrophenone derivatives].
Vetulani J. Vetulani J. Postepy Hig Med Dosw. 1969 Sep-Oct;23(5):661-705. Postepy Hig Med Dosw. 1969. PMID: 4908589 Review. Polish. No abstract available.
Cited by
- Toward personalized circuit-based closed-loop brain-interventions in psychiatry: using symptom provocation to extract EEG-markers of brain circuit activity.
Zrenner B, Zrenner C, Balderston N, Blumberger DM, Kloiber S, Laposa JM, Tadayonnejad R, Trevizol AP, Zai G, Feusner JD. Zrenner B, et al. Front Neural Circuits. 2023 Aug 21;17:1208930. doi: 10.3389/fncir.2023.1208930. eCollection 2023. Front Neural Circuits. 2023. PMID: 37671039 Free PMC article. Review. - The Arousal-motor Hypothesis of Dopamine Function: Evidence that Dopamine Facilitates Reward Seeking in Part by Maintaining Arousal.
Kaźmierczak M, Nicola SM. Kaźmierczak M, et al. Neuroscience. 2022 Sep 1;499:64-103. doi: 10.1016/j.neuroscience.2022.07.008. Epub 2022 Jul 16. Neuroscience. 2022. PMID: 35853563 Free PMC article. - Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.
Kamgar-Dayhoff P, Brelidze TI. Kamgar-Dayhoff P, et al. Oncotarget. 2021 Jul 6;12(14):1406-1426. doi: 10.18632/oncotarget.28010. eCollection 2021 Jul 6. Oncotarget. 2021. PMID: 34262651 Free PMC article. - Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia.
Borroto-Escuela DO, Ferraro L, Narvaez M, Tanganelli S, Beggiato S, Liu F, Rivera A, Fuxe K. Borroto-Escuela DO, et al. Cells. 2020 Apr 27;9(5):1077. doi: 10.3390/cells9051077. Cells. 2020. PMID: 32349279 Free PMC article. Review. - Dopamine in psychiatry: a historical perspective.
Foley PB. Foley PB. J Neural Transm (Vienna). 2019 Apr;126(4):473-479. doi: 10.1007/s00702-019-01987-0. Epub 2019 Feb 13. J Neural Transm (Vienna). 2019. PMID: 30758785 Review.